The authors of the following paper would like to draw the reader’s attention to an error in the article:

Güngördük K, Asicioglu O, Celikkol O, Olgac Y, Ark C. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Aust N Z J Obstet Gynaecol. 2010; 50: 36–39.

On page 37, we would like to correct that the manufacturer of the preferred oxytocin is SYNPITAN FORT Deva Ilac, Istanbul, Turkey.

Reference 16 also was missed in the list of references, and should read:

16. Murphy DJ, MacGregor H, Munishankar B, McLeod G. A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section--pilot study. ISRCTN 40302163. Eur J Obstet Gynecol Reprod Biol. 2009 Jan; 142(1): 30–33.

The authors apologise for this error and any confusion it may have caused.